...
首页> 外文期刊>Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research >Familial hypocalciuric hypercalcemia caused by an R648stop mutation in the calcium-sensing receptor gene.
【24h】

Familial hypocalciuric hypercalcemia caused by an R648stop mutation in the calcium-sensing receptor gene.

机译:由钙敏感受体基因中的R648stop突变引起的家族性低钙血症。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In this study, we report an 84-year-old female proband in a Japanese family with familial hypocalciuric hypercalcemia (FHH) caused by an R648stop mutation in the extracellular calcium-sensing receptor (CaR) gene. At the age of 71 years, she presented with hypercalcemia (11.4 mg/dl), hypocalciuria (Cca/Ccr = 0.003), hypermagnesemia (2.9 mg/dl), and a high-serum parathyroid hormone (PTH) level (midregion PTH, 3225 [160-520] pg/ml). At the age of 74 years, a family screening was carried out and revealed a total of 9 hypercalcemic individuals (all intact PTH values <62 pg/dl) among 17 family members tested, thus, being diagnosed as FHH. Two and one-half of three clearly enlarged parathyroid glands were resected, because persistently high PTH levels (intact PTH, 292 pg/ml; midregion PTH, 5225 pg/ml) and the presence of a markedly enlarged parathyroid gland by several imaging modalities (ultrasonography, computed tomography [CT], magnetic resonance imaging [MRI], and subtraction scintigraphy) suggested coexistent primary hyperparathyroidism (pHPT); however, hypercalcemia persisted postoperatively. Histological and immunohistochemical examination revealed that the resected parathyroid glands showed lipohyperplasia as well as normally expressed Ki67, vitamin D receptor (VDR), and the CaR. Sequence analysis disclosed that the proband and all affected family members had a heterozygous nonsense (R648stop) mutation in the CaR gene. This mutation is located in the first intracellular loop; thus, it would be predicted to produce a truncated CaR having only one transmembrane domain (TMD) and lacking its remaining TMDs, intracellular loops, and C-terminal tail. Western analysis of biotinylated HEK293 cells transiently transfected with this mutant receptor showed cell surface expression of the truncated protein at a level comparable with that of the wild-type CaR. The mutant receptor, however, exhibited no increase in intracellular free calcium concentration (Ca2+i) when exposed to high extracellular calcium concentrations (Ca2+o). The proband's clinical course was complicated because of associated renal tubular acidosis (RTA) and nephrotic syndrome. However, it was unclear whether their association affected the development of elevated serum PTH and parathyroid gland enlargement. This report is the first to show that an R648stop CaR mutation yields a truncated receptor that is expressed on the cell surface but is devoid of biological activity, resulting in FHH.
机译:在这项研究中,我们报告了一个日本家庭中的84岁女性先证者,该患者患有由细胞外钙敏感受体(CaR)基因中的R648stop突变引起的家族性低钙血症(FHH)。在71岁时,她出现高钙血症(11.4 mg / dl),低钙尿(Cca / Ccr = 0.003),高镁血症(2.9 mg / dl)和高血清甲状旁腺激素(PTH)水平(中位PTH, 3225 [160-520] pg / ml)。在74岁的时候,进行了一次家庭筛查,发现被测的17个家庭成员中共有9名高钙血症个体(所有完整的PTH值<62 pg / dl)。切除了三个明显扩大的甲状旁腺的二分之一和二分之一,因为持续存在较高的PTH水平(完整PTH,292 pg / ml;中部PTH,5225 pg / ml),并且通过几种成像方式显着增大了甲状旁腺超声,计算机断层扫描[CT],磁共振成像[MRI]和减影闪烁显像)提示并发原发性甲状旁腺功能亢进症(pHPT)。但是,术后高钙血症持续存在。组织学和免疫组织化学检查显示,切除的甲状旁腺显示出脂肪增生,并正常表达Ki67,维生素D受体(VDR)和CaR。序列分析显示,先证者和所有受影响的家庭成员在CaR基因中均具有杂合无义(R648stop)突变。该突变位于第一个细胞内环中。因此,预计将产生仅具有一个跨膜结构域(TMD)且缺少其剩余TMD,细胞内环和C末端尾巴的截短的CaR。对该突变受体瞬时转染的生物素化HEK293细胞的Western分析表明,截短蛋白的细胞表面表达水平与野生型CaR相当。但是,突变受体在暴露于高细胞外钙浓度(Ca2 + o)时,细胞内游离钙浓度(Ca2 + i)没有增加。由于伴有肾小管酸中毒(RTA)和肾病综合症,先证者的临床过程很复杂。然而,尚不清楚它们的关联是否影响血清PTH升高和甲状旁腺增大的发展。该报道首次显示R648stop CaR突变产生截短的受体,该受体在细胞表面表达但缺乏生物活性,从而导致FHH。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号